DE3931147A1 - New nerve tonic contg. extract of avena sativa - used to treat frigidity and increase libido in women - Google Patents
New nerve tonic contg. extract of avena sativa - used to treat frigidity and increase libido in womenInfo
- Publication number
- DE3931147A1 DE3931147A1 DE19893931147 DE3931147A DE3931147A1 DE 3931147 A1 DE3931147 A1 DE 3931147A1 DE 19893931147 DE19893931147 DE 19893931147 DE 3931147 A DE3931147 A DE 3931147A DE 3931147 A1 DE3931147 A1 DE 3931147A1
- Authority
- DE
- Germany
- Prior art keywords
- extract
- alcoholic
- nerve tonic
- nerve
- tonic according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001256 tonic effect Effects 0.000 title claims abstract description 26
- 235000007319 Avena orientalis Nutrition 0.000 title claims abstract description 14
- 239000000284 extract Substances 0.000 title claims abstract description 12
- 210000005036 nerve Anatomy 0.000 title claims description 25
- 208000021663 Female sexual arousal disease Diseases 0.000 title abstract description 3
- 208000006262 Psychological Sexual Dysfunctions Diseases 0.000 title abstract description 3
- 241000209763 Avena sativa Species 0.000 title 1
- 239000012675 alcoholic extract Substances 0.000 claims abstract description 26
- 244000075850 Avena orientalis Species 0.000 claims abstract description 13
- 240000006927 Foeniculum vulgare Species 0.000 claims abstract description 6
- 235000004204 Foeniculum vulgare Nutrition 0.000 claims abstract description 6
- 240000003589 Impatiens walleriana Species 0.000 claims abstract description 4
- 241000219094 Vitaceae Species 0.000 claims abstract description 4
- 235000021021 grapes Nutrition 0.000 claims abstract description 4
- 241000219095 Vitis Species 0.000 claims abstract description 3
- 235000009392 Vitis Nutrition 0.000 claims abstract description 3
- 241001529742 Rosmarinus Species 0.000 claims description 5
- 244000025221 Humulus lupulus Species 0.000 claims description 4
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 4
- 235000017309 Hypericum perforatum Nutrition 0.000 claims description 4
- 244000141009 Hypericum perforatum Species 0.000 claims description 4
- 235000013532 brandy Nutrition 0.000 claims description 4
- 235000013339 cereals Nutrition 0.000 claims description 4
- 241000218228 Humulus Species 0.000 claims description 2
- 244000178231 Rosmarinus officinalis Species 0.000 claims description 2
- 230000036512 infertility Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 235000015639 rosmarinus officinalis Nutrition 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 230000001914 calming effect Effects 0.000 abstract description 4
- 230000002040 relaxant effect Effects 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 description 14
- 241000196324 Embryophyta Species 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000002803 maceration Methods 0.000 description 3
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010024421 Libido increased Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 206010000230 Abortion missed Diseases 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/235—Foeniculum (fennel)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Die Erfindung betrifft ein Nerventonikum für Frauen zum Abbau psychisch bedinger Sterilität.The invention relates to a nerve tonic for women to break down psychologically related sterility.
Zahlreiche Frauen sind, sei es aufgrund Erziehung oder aufgrund von traumatischen Erlebnissen nicht in der Lage, mit einem Partner in Sexualkontakt zu treten. Selbst wenn ein Sexual kontakt stattfinden sollte, erfolgt dieser in gefühlskaltem Zustand (Frigidität) oder mit verminderter Libido. Numerous women are there, either because of upbringing or because of of traumatic experiences unable to cope with one Partner in sexual contact. Even if a sexual contact should take place, this takes place in emotionally cold Condition (frigidity) or with reduced libido.
Es wurde ferner festgestellt, daß Frauen, die unter derart psychischen Störungen leiden, selbst dann, wenn sie einen Partner gefunden haben, mit dem sie einen Sexualkontakt wünschen, beim Versuch des Vollzug des Sexualkontaktes eine innere Hemmschwelle nicht überwinden können, was dann dazu führt, daß entweder überhaupt kein Sexualkontakt zustande kommt, oder nur ein Sexualkontakt mit verminderter Libido.It has also been found that women who are under such suffer from mental disorders, even if they do Have found partners with whom they have sexual contact wish when attempting sexual contact one can not overcome internal inhibition threshold, which leads to this leads to either no sexual contact at all comes, or just sexual contact with decreased libido.
Aufgabe der vorliegenden Erfindung ist daher, ein Nerventonikum der eingangs genannten Art zu schaffen, das für eine solche Entspannung sorgt, daß ein Sexualkontakt zustande kommen kann, und daß dieser dann mit erhöhter Libido stattfinden kann.The object of the present invention is therefore a nerve tonic of the type mentioned at the outset, for such Relaxation ensures that sexual contact can take place and that this can then take place with increased libido.
Erfindungsgemäß wird die Aufgabe durch ein Nerventonikum gelöst, das aus einer Mischung besteht, die alkoholische Auszüge aus Avena sativa (Hafer) und Fructus Vitis viniverae (getrockenete Weintrauben) enthält.According to the invention, the object is achieved by a nerve tonic, which consists of a mixture that consists of alcoholic extracts Avena sativa (oat) and Fructus Vitis viniverae (dry Grapes) contains.
Die Kombination der alkoholischen Auszüge verursacht eine Entspannung und Entkrampfung und wirkt, während des Vollzuges des Sexualkontaktes insoweit narkotisierend, daß die innere ablehnende Hemmschwelle soweit herabgesetzt wird, daß eine ungebremste Libido ermöglicht ist.The combination of alcoholic extracts causes one Relaxation and relaxation and works during the execution of sexual contact to the extent that the inner negative inhibition threshold is reduced so far that a unrestrained libido is enabled.
In besonders vorteilhaften Ausgestaltung der Erfindung werden alkoholische Auszüge aus blühendem Hafer, insbesondere ein Auszug aus Rispen von grünem, im Blütestadium befindlichem Hafer eingesetzt. Die Auszüge aus diesen Pflanzenteilen wirken besonders stark. In a particularly advantageous embodiment of the invention alcoholic extracts from flowering oats, especially one Extract from panicles of green, in the flowering stage Oats used. The extracts from these parts of the plant work especially strong.
In einer weiteren vorteilhaften Ausgestaltung der Erfindung ist ein alkoholischer Auszug aus hellen, ungebleichten Kali fornischen Sultaninen enthalten. Auch in dieser Ausgestaltung wird die Wirksamkeit beträchtlich erhöht.In a further advantageous embodiment of the invention is an alcoholic extract from bright, unbleached potash contain fornic sultanas. Also in this configuration the effectiveness is increased considerably.
In weiteren vorteilhaften Ausgestaltungen der Erfindung sind die alkoholischen Auszüge a) und b) im Gewichtsverhältnis a) : b) zwischen 0,1 und 10, vorzugsweise zwischen 0,5 und 5, und insbesondere im Gewichtsverhältnis 1 : 1 enthalten.In further advantageous embodiments of the invention the alcoholic extracts a) and b) in weight ratio a): b) between 0.1 and 10, preferably between 0.5 and 5, and especially in a weight ratio of 1: 1.
Diese Maßnahme hat den Vorteil, daß im Bereich dieser Gewichts verhältnisse die Kombination der Auszüge besonders wirksam ist, d.h., daß eine besonders günstige Abstimmung der beiden Komponente aufeinander erreicht ist.This measure has the advantage that in the range of this weight the combination of extracts is particularly effective is, that is a particularly favorable coordination of the two Component is reached on each other.
In einer weiteren vorteilhaften Ausgestaltung ist das Aus zugsmittel ein 38%iger Kornbranntwein, der auch Lösungsmittel des Tonikums ist.In a further advantageous embodiment, the end a 38% grain brandy, which also contains solvents of the tonic is.
Diese Maßnahme hat den Vorteil, daß das Nerventonikum wohl schmeckend, verträglich und rasch vom Körper aufgenommen werden kann, so daß es seine Wirkung alsbald entfalten kann, daher eine Einnahme kurz vor oder in der Vorbereitungsphase eines Sexualkontaktes ausreicht.This measure has the advantage that the nerve tonic is well tasting, well tolerated and quickly absorbed by the body can, so that it can have its effect immediately, hence an intake shortly before or in the preparation phase of a Sexual contact is sufficient.
In einer weiteren Ausgestaltung der Erfindung ist zusätzlich ein alkoholischer Auszug aus Foeniculum vulgare (Fenchel) oder Fructus Foeniculi pulv. enthalten.In a further embodiment of the invention is additional an alcoholic extract from Foeniculum vulgare (fennel) or Fructus Foeniculi pulv.
Diese Maßnahme hat den Vorteil, daß eine zusätzlich gesteigerte entspannende und beruhigende Wirkung erzielt werden kann. This measure has the advantage that an additional increase relaxing and calming effect can be achieved.
In einer weiteren vorteilhaften Ausgestaltung der Erfindung ist zusätzlich ein alkoholischer Auszug aus Rosmarinus offi cinalis (Rosmarin) oder Folia Rosmarini (Rosmarinblättern) enthalten.In a further advantageous embodiment of the invention is also an alcoholic extract from Rosmarinus offi cinalis (rosemary) or Folia rosemary (rosemary leaves) contain.
Diese Maßnahme hat den Vorteil, daß eine gesteigerte Durch blutung des Körpers erreicht wird, die ebenfalls zum raschen Abbau der inneren Hemmschwellen beiträgt.This measure has the advantage that an increased through Bleeding of the body is achieved, which is also rapid Reduction of the inner inhibitions contributes.
In einer weiteren vorteilhaften Ausgestaltung der Erfindung ist zusätzlich ein alkoholischer Auszug aus Humulus Lupulus (Hopfen), oder insbesondere ein alkoholischer Auszug aus Strobuli Lupuli (zapfenförmige Blütenstände des Hopfens) enthalten.In a further advantageous embodiment of the invention is also an alcoholic extract from Humulus Lupulus (Hops), or especially an alcoholic extract from Strobuli Lupuli (cone-shaped inflorescences of the hop) contain.
Diese Maßnahme hat den Vorteil, daß eine zusätzlich beruhigende Wirkung erreicht werden kann. Eine innere Beruhigung wurde insbesondere bei solchen Frauen erreicht, die ihrer psychischen Störung bewußt sind, und die bei einem bevorstehenden Sexualkon takt, den sie selbst wünschen, befürchten, daß aufgrund früherer Erfahrungen Störungen beim Vollzug des Sexualkontaktes zu erwarten sind, was sich in einer die ablehnende Haltung stei gernden inneren Beunruhigung ausdrückt.This measure has the advantage that an additional soothing Effect can be achieved. An inner reassurance was especially achieved in those women who have their psychological Are aware of the disorder, and that of an upcoming sexual con tact, which you wish yourself, fear that due to earlier Experiences disruptions in the execution of sexual contact expect what is in a negative attitude expressing annoyance.
In einer weiteren vorteilhaften Ausgestaltung der Erfindung ist zusätzlich ein alkoholischer Auszug aus Hypericum perforatum (Johanniskraut) enthalten.In a further advantageous embodiment of the invention is also an alcoholic extract from Hypericum perforatum (St. John's wort) included.
Diese Maßnahme hat den Vorteil, daß eine ruhigstellende Wirkung auf die Nerven und zwar im Hinblick auf das Substrat, d.h. also die Leitung der Nervenreize als auch auf die Funktion des Nerves als solches erreicht werden kann. This measure has the advantage that it has a sedative effect on the nerves with regard to the substrate, i.e. thus the direction of the nerve stimuli as well as on the function of the nerve as such can be achieved.
Es versteht sich, daß die vorstehend genannten und die nach stehend noch zu erläuternden Merkmale nicht nur in der jeweils angegebenen Kombination, sondern auch in anderen Kombinationen und in Alleinstellung einsetzbar sind, ohne den Rahmen der vorliegenden Erfindung zu verlassen.It is understood that the above and the following standing features to be explained not only in each specified combination, but also in other combinations and can be used alone, without the scope of the to leave the present invention.
Die Pflanzenteile werden bei 27°C in einen Kornbranntwein mit 38 Vol.-% Ethylalkohol gegeben (Mazeration). Die Mazeration erfolgt über einen Zeitraum von 11 Tagen, währenddessen der Ansatz mehrmals täglich von Hand durchgerührt wird. Die flüssige alkoholische Phase wird anschließend von den verbleibenden Feststoffen durch Filtration abgetrennt.The parts of the plant are put into a grain brandy at 27 ° C 38 vol .-% ethyl alcohol given (maceration). The maceration takes place over a period of 11 days, during which the Approach is carried out by hand several times a day. The liquid alcoholic phase is then left by the remaining Solids separated by filtration.
In 100 ml eines 38 Vol.-% Kornbranntweines werden 1,1 g helle, jedoch ungebleichte Kalifornische Sultaninen kleingehackt gegeben.In 100 ml of a 38 vol.% Grain brandy, 1.1 g of light, however, unbleached California sultanas chopped given.
Ferner werden 1,1 g kleingeschnittene Rispen von grünem, im Blütestadium befindlichem Hafer zugegeben.Furthermore, 1.1 g finely chopped panicles of green, in Added oat at the flowering stage.
Der entsprechend der allgemeinen zuvor gegebenen Mazerations vorschrift enthaltene alkoholische Auszug, kann direkt als Nerventonikum eingesetzt werden.The one according to the general maceration given earlier regulation contained alcoholic extract, can be used directly as Nerve tonic can be used.
Die Einnahme von 20 cm3 dieses alkoholischen Auszuges in der Vorbereitungsphase vor einem Sexualkontakt, erreichte bei verschiedenen Frauen eine beruhigende, leicht narkotisierende Wirkung, wodurch eine Herabsetzung der psychisch bedingten Hemmschwelle zur Bereitschaft der Durchführung des Sexualkon taktes erreicht werden konnte, und wobei auch bei der Durch führung des Sexualkontaktes über eine erhebliche Entspannung und Entkrampfung berichtet wurde, die eine gesteigerte Libido ermöglicht hat.Taking 20 cm 3 of this alcoholic extract in the preparatory phase before sexual contact achieved a calming, slightly narcotic effect in various women, which reduced the psychologically-related inhibition threshold for the willingness to conduct the sexual contact, and also in the case of Significant relaxation and relaxation were reported through the conduct of sexual contact, which made an increased libido possible.
In 100 ml eines 38 Vol.-%iges Kornbranntweines werden außer
den in Beispiel 1 aufgeführten Pflanzenteile (Rosinen, Hafer)
noch zusätzlich folgende Pflanzenteile gegeben.
500 mg Fructus Foeniculi pulv.
500 mg Folia Rosmarini
500 mg Strobuli Lupuli
300 mg Herba Hyperici.In addition to the parts of plants (raisins, oats) listed in Example 1, the following parts of plants are added to 100 ml of a 38 vol.
500 mg Fructus Foeniculi pulv.
500 mg folia rosemary
500 mg strobuli lupuli
300 mg Herba Hyperici.
Auch dieser Ansatz wurde entsprechend der allgemeinen Maze rationsvorschrift behandelt, wobei ein Ansatz die Größe von 0,75 l nicht überschreitet. Die resultierende flüssige alko holische Phase kann direkt als Nerventonikum eingesetzt werden. Bei Einsatz dieses Mittels wurde eine besonders entspannende, beruhigende Wirkung beobachtet, die sich in eine Beruhigung der Nerven unter gleichzeitiger Steigerung der Durchblutung äußert.This approach was also in line with the general maze ration rule, taking one approach the size of Does not exceed 0.75 l. The resulting liquid alko holic phase can be used directly as a nerve tonic. When using this product, a particularly relaxing, Soothing effects are observed, resulting in a calming effect of the nerves while increasing blood circulation expresses.
Claims (14)
- a) Avena sativa (Hafer)
- b) Fructus Vitis viniverae (getrocknete Weintrauben) enthält.
- a) Avena sativa (oats)
- b) contains fructus vitis viniverae (dried grapes).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893931147 DE3931147A1 (en) | 1989-09-19 | 1989-09-19 | New nerve tonic contg. extract of avena sativa - used to treat frigidity and increase libido in women |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19893931147 DE3931147A1 (en) | 1989-09-19 | 1989-09-19 | New nerve tonic contg. extract of avena sativa - used to treat frigidity and increase libido in women |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3931147A1 true DE3931147A1 (en) | 1991-03-28 |
DE3931147C2 DE3931147C2 (en) | 1992-12-24 |
Family
ID=6389677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19893931147 Granted DE3931147A1 (en) | 1989-09-19 | 1989-09-19 | New nerve tonic contg. extract of avena sativa - used to treat frigidity and increase libido in women |
Country Status (1)
Country | Link |
---|---|
DE (1) | DE3931147A1 (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2182708A1 (en) * | 2001-07-05 | 2003-03-01 | Velasquez Rene Gabriel Bustos | Diuretic wine dissolving accumulated fat consists of vine, thyme, rosemary and juniper with additives and citrus juice |
US7270835B2 (en) | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7332185B2 (en) | 2001-06-20 | 2008-02-19 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
US7718198B2 (en) | 2001-06-20 | 2010-05-18 | Metaproteomics, Llc | Treatment modalities for autoimmune diseases |
US7722903B2 (en) | 2001-06-20 | 2010-05-25 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
US7790205B2 (en) | 2002-10-21 | 2010-09-07 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7807203B2 (en) | 2001-06-20 | 2010-10-05 | Metaprotemics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
US7811610B2 (en) | 2003-05-22 | 2010-10-12 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
WO2013028140A1 (en) | 2011-08-23 | 2013-02-28 | Eraslan Mustafa | Tribulus terrestris, avena sativa and panax ginseng extract combination |
US8557306B2 (en) | 2001-06-20 | 2013-10-15 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US8815306B2 (en) | 2007-03-19 | 2014-08-26 | Metaproteomics, Llc | Methods and compositions for promoting bone and joint health |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7901714B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llp | Treatment modalities for autoimmune diseases |
US8206753B2 (en) | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
US7901713B2 (en) | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
JP2006508182A (en) | 2002-10-21 | 2006-03-09 | メタプロテオミクス, エルエルシー | A composition for treating or inhibiting a pathological condition associated with an inflammatory response. |
US7914831B2 (en) | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
JP2009504657A (en) | 2005-08-09 | 2009-02-05 | メタプロテオミクス,エルエルシー | Protein kinase regulation by hops and acacia products |
JP2010526882A (en) | 2007-05-11 | 2010-08-05 | メタプロテオミクス, エルエルシー | Methods and compositions for detoxifying heavy metals |
-
1989
- 1989-09-19 DE DE19893931147 patent/DE3931147A1/en active Granted
Non-Patent Citations (3)
Title |
---|
Deutsche Apothekerzeitung, 1984, 2059-60 * |
HAGER: Handbuch der Pharm. Praxis, 4. Aufl., Springer Berlin 1979, Bd. VI, S. 500 und 501 * |
PAHLOW, M.: Das große Buch der Heilpflanzen, Gräfe und Unzer, München 1985, S. 150-152, 136, 137, 174, 175, 182, 183, 272-274 * |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7807203B2 (en) | 2001-06-20 | 2010-10-05 | Metaprotemics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
US7332185B2 (en) | 2001-06-20 | 2008-02-19 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
US8557306B2 (en) | 2001-06-20 | 2013-10-15 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7815944B2 (en) | 2001-06-20 | 2010-10-19 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity |
US7718198B2 (en) | 2001-06-20 | 2010-05-18 | Metaproteomics, Llc | Treatment modalities for autoimmune diseases |
US7722903B2 (en) | 2001-06-20 | 2010-05-25 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
US7919125B2 (en) * | 2001-06-20 | 2011-04-05 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
US7794757B2 (en) | 2001-06-20 | 2010-09-14 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
US7820206B2 (en) | 2001-06-20 | 2010-10-26 | Metaproteomics, Llc | Modulation of inflammation by hops fractions and derivatives |
US7270835B2 (en) | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7431948B2 (en) | 2001-06-20 | 2008-10-07 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
ES2182708A1 (en) * | 2001-07-05 | 2003-03-01 | Velasquez Rene Gabriel Bustos | Diuretic wine dissolving accumulated fat consists of vine, thyme, rosemary and juniper with additives and citrus juice |
US8158160B2 (en) | 2001-11-13 | 2012-04-17 | Eric Hauser Kuhrts | Anti-inflammatory cyclooxygenase inhibitors |
US7790205B2 (en) | 2002-10-21 | 2010-09-07 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US8142819B2 (en) * | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US7811610B2 (en) | 2003-05-22 | 2010-10-12 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
US8815306B2 (en) | 2007-03-19 | 2014-08-26 | Metaproteomics, Llc | Methods and compositions for promoting bone and joint health |
WO2013028140A1 (en) | 2011-08-23 | 2013-02-28 | Eraslan Mustafa | Tribulus terrestris, avena sativa and panax ginseng extract combination |
Also Published As
Publication number | Publication date |
---|---|
DE3931147C2 (en) | 1992-12-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3931147C2 (en) | ||
EP1073445B1 (en) | Substance mixture for topical application comprising olive oil and honey | |
DE3784522T2 (en) | MEDICAL COMPOSITIONS AGAINST PSORIASIS. | |
EP0730830A1 (en) | Process for removing unwanted lipophilic impurity or residue from drinks or vegetable preparations | |
DE2019226B2 (en) | Cosmetic agent | |
DE3705151A1 (en) | WARTS | |
DE4118098C1 (en) | ||
DE69802545T2 (en) | PROPOLIS AND AT LEAST ONE COMPOSITION CONTAINING ESSENTIAL OIL | |
EP0904092B1 (en) | Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use | |
DE3442961C1 (en) | Hair care composition | |
EP3823464A1 (en) | Method for removing impurities from vegetable preparations | |
Vogellehner | Zur Nomenklatur der fossilen Holzgattung Dadoxylon Endlicher 1847 | |
DE2912438C2 (en) | ||
WO1994011009A1 (en) | Composition for controlling dermatomycoses and their agents, as well as transpiration and bodily odours | |
CH682631A5 (en) | Herbal compsns. for promoting hair growth - contain nettle, pansy and chickweed | |
DE19821971C2 (en) | Medicines for the treatment of psoriasis or atopic dermatitis | |
DE4220182A1 (en) | Pharmaceutical camomile extracts - contg. essential components in propylene glycol and/or glycerol | |
DE3931693C2 (en) | ||
DE4237551C1 (en) | Use of a plant-based composition to combat dermatomycoses | |
DE10085492T5 (en) | Antimonocyte activity of betel pepper leaf extracts | |
DE4236409C1 (en) | New use of compsns. contg. garlic and fenugreek - for oral treatment of diabetes | |
Fahrländer | Über Hefe-und Schimmelpilzallergien mit gastrointestinaler Reizantwort | |
DE2551962C3 (en) | Use of an extract from different species of Helleborus | |
DE712651C (en) | Process for the preparation of laxatives acting on the large intestine | |
DE19910697C2 (en) | Process for the preparation of a therapeutically active substance and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
8127 | New person/name/address of the applicant |
Owner name: WEIL, WALTER, DIPL.-BIOL., 7600 OFFENBURG, DE |
|
D2 | Grant after examination | ||
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |